GE

272.05

-1.46%↓

RTX

156.35

-0.77%↓

GEV.US

650.28

-1.91%↓

HON

220.91

+0.12%↑

UNP

222.99

+0.45%↑

GE

272.05

-1.46%↓

RTX

156.35

-0.77%↓

GEV.US

650.28

-1.91%↓

HON

220.91

+0.12%↑

UNP

222.99

+0.45%↑

GE

272.05

-1.46%↓

RTX

156.35

-0.77%↓

GEV.US

650.28

-1.91%↓

HON

220.91

+0.12%↑

UNP

222.99

+0.45%↑

GE

272.05

-1.46%↓

RTX

156.35

-0.77%↓

GEV.US

650.28

-1.91%↓

HON

220.91

+0.12%↑

UNP

222.99

+0.45%↑

GE

272.05

-1.46%↓

RTX

156.35

-0.77%↓

GEV.US

650.28

-1.91%↓

HON

220.91

+0.12%↑

UNP

222.99

+0.45%↑

Search

SkyWest Inc

Gesloten

SectorIndustrieën

109.23 -0.32

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

107.12

Max

110.86

Belangrijke statistieken

By Trading Economics

Inkomsten

120M

120M

Verkoop

87M

1B

K/W

Sectorgemiddelde

11.967

42.612

EPS

2.42

Winstmarge

11.618

Werknemers

12,876

EBITDA

-11M

172M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+21.67% upside

Dividenden

By Dow Jones

Volgende Winsten

30 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

206M

4.8B

Vorige openingsprijs

109.55

Vorige sluitingsprijs

109.23

Nieuwssentiment

By Acuity

28%

72%

93 / 461 Rangschikking in Industrials

SkyWest Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 aug 2025, 21:42 UTC

Winsten
Acquisities, Fusies, Overnames

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 aug 2025, 21:21 UTC

Winsten
Belangrijke Marktbewegers

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 aug 2025, 20:45 UTC

Winsten

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 aug 2025, 19:15 UTC

Belangrijke Marktbewegers

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 aug 2025, 23:41 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

4 aug 2025, 23:41 UTC

Marktinformatie

Nikkei May Rise on Fed Stimulus Hopes

4 aug 2025, 23:28 UTC

Marktinformatie

Global Equities Roundup: Market Talk

4 aug 2025, 23:28 UTC

Marktinformatie

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 aug 2025, 21:30 UTC

Winsten

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 aug 2025, 21:21 UTC

Winsten
Acquisities, Fusies, Overnames

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 aug 2025, 21:18 UTC

Winsten

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 aug 2025, 20:25 UTC

Marktinformatie

India Hits Back Over Russian Oil Purchases -- Market Talk

4 aug 2025, 20:25 UTC

Winsten

Transocean 2Q Loss $938M >RIG

4 aug 2025, 20:25 UTC

Winsten

Transocean 2Q Loss/Shr $1.06 >RIG

4 aug 2025, 20:18 UTC

Winsten

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 aug 2025, 20:15 UTC

Winsten

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 aug 2025, 20:14 UTC

Winsten

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 aug 2025, 20:14 UTC

Winsten

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 aug 2025, 20:14 UTC

Winsten

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 aug 2025, 20:13 UTC

Winsten

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 aug 2025, 20:09 UTC

Winsten

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 aug 2025, 20:06 UTC

Winsten

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 aug 2025, 20:01 UTC

Winsten

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 aug 2025, 20:01 UTC

Winsten

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 aug 2025, 20:01 UTC

Winsten

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 aug 2025, 20:01 UTC

Winsten

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 aug 2025, 19:41 UTC

Marktinformatie

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 aug 2025, 19:28 UTC

Marktinformatie

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 aug 2025, 19:07 UTC

Marktinformatie

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 aug 2025, 18:27 UTC

Marktinformatie

Gold Climbs on Rate Cut Speculation -- Market Talk

Peer Vergelijking

Prijswijziging

SkyWest Inc Prognose

Koersdoel

By TipRanks

21.67% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 132.75 USD  21.67%

Hoogste 140 USD

Laagste 125 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor SkyWest Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

4 ratings

4

Buy

0

Hold

0

Sell

Sentiment

By Acuity

93 / 461 Rangschikking in Industrieën

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over SkyWest Inc

SkyWest, Inc., through its subsidiaries, engages in the operation of a regional airline in the United States. It operates through two segment, SkyWest Airlines and SWC; and SkyWest Leasing. The company is also involved in leasing regional jet aircraft and spare engines to third parties; and provision of on-demand charter, airport customer, and ground handling services. As of December 31, 2023, its fleet consisted of 603 aircraft; and provided scheduled passenger and air freight services with approximately 1,850 total daily departures to various destinations in the United States, Canada, and Mexico. SkyWest, Inc. was incorporated in 1972 and is headquartered in Saint George, Utah.